MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / News Well / Johnson & Johnson plans to file for approval 30 “major” products | Medtech Wall Street news for the week of May 26, 2014

Johnson & Johnson plans to file for approval 30 “major” products | Medtech Wall Street news for the week of May 26, 2014

May 29, 2014 By MassDevice Leave a Comment

J&J's pipeline includes 30 'major' medical devices and a surgical robot

May 22, 2014 by Brad Perriello

J&J plans to launch 30 major medical device filings over the next 2 years

Johnson & Johnson’s medical device & diagnostics division plans to file for approval for some 30 “major” products over the next 3 years from regulators, executives told analysts today at an investors meeting.

The pipeline includes planned filings for orthopedic, surgical and diabetes care devices in the U.S., Europe and Japan through 2016 – and an entry into the robot-assisted surgery arena, executives said at the meeting today in New Brunswick, N.J. Read more

U.K. regulators OK Smith & Nephew's $1.7B ArthroCare buy

May 22, 2014 by Brad Perriello

U.K. regulators OK Smith & Nephew's $1.7B ArthroCare buy

British anti-trust regulators approved the $1.7 billion acquisition of ArthroCare by Smith & Nephew, ArthroCare said yesterday, clearing the way for a closing by May 29.

The U.K.’s Competition and Markets Authority granted “unconditional clearance” for the merger yesterday, ArthroCare said in a regulatory filing. Read more

Echo Therapeutics proxy war gets ugly amid alleged threats

May 23, 2014 by Arezu Sarvestani

Echo Therapeutics proxy war gets ugly amid alleged threats

Embattled Echo Therapeutics issued a new volley against its proxy war rival and largest shareholder Platinum Group, accusing the activist investor of conspiring to tank the company’s stock.

Echo claimed today that a Platinum leader threatened the company’s former CEO via text message, adding that the investment had made some recent deals that hurt other stockholders while lining the company’s coffers. Read more

Symmetry Medical sells off Clamonta aerospace subsidiary

May 22, 2014 by Brad Perriello

Symmetry Medical sells of Clamonta aerospace subsidiary

Symmetry Medical’s said today that it sold its Clamonta Ltd. aerospace subsidiary to the HLDF Corp. for roughly $1.3 million (£0.8 million), but remains committed to the aerospace machining market.

The move prompted Symmetry to cut its guidance for 2014, sending share prices down slightly on Wall Street. Read more

Analogic cuts guidance, shares hit 2-year low

May 27, 2014 by Brad Perriello

Analogic cuts guidance, shares hit 2-year low

Analogic today cut its forecast for the rest of fiscal 2014 for the 2nd time in as many months, sending share prices to a near-2-year low today on Wall Street.

Peabody, Mass.-based Analogic said it now expects to post earnings of 62¢ per share, or 94¢ when adjusted to exclude 1-time items, on sales of $124 million for its fiscal 3rd quarter ended April 30. Analysts on The Street were looking for adjusted EPS of 1.09. Read more

Filed Under: News Well, Wall Street Beat Tagged With: Analogic, ArthroCare Corp., Echo Therapeutics Inc., Johnson and Johnson, Platinum Management, Smith & Nephew, Symmetry Medical Inc., U.K. Competition and Markets Authority

In case you missed it

  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results
  • FDA details framework for abbreviated 510(k) medical device review pathway
  • Drug or device? FDA loses this argument for now
  • Aptar wins FDA clearance for ready-to-use seizure treatment device
  • Aurora Bio touts PET radiotracer data
  • Medical device excise tax would reduce R&D spending, report says
  • Proteus Digital Health restructuring amid reported funding woes
  • GE Healthcare partnering on regenerative tissue manufacturing
  • Schiller issues field safety notice for Tempus LS defibrillators
  • Report: 3M may sell off its drug-delivery business for $1 billion
  • Abbott issues field safety notice for Heartmate 3 LVAS power unit

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS